Coronary artery disease: Revascularization strategies for patients with CAD and diabetes

Nature Reviews Cardiology

Volumn 7, Issue 7, 2010, Pages 364-366

  Myers, G Robert ^a   Weintraub, William S ^a  

^a CHRISTIANA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ELUTING STENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SHORT SURVEY; STROKE; SURGICAL APPROACH; SURGICAL TECHNIQUE;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77954165069     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.82     Document Type: Short Survey

References (10)

1. serruys, P. w. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 360, 961-972 (2009).
2. Banning, A. P. et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J. Am. Coll. Cardiol. 55, 1067-1075 (2010).
3. The BARi investigators. influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization investigation (BARi). Circulation 96, 1761-1769 (1997).
4. Hlatky, M. A. et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomized trials. Lancet 373, 1190-1197 (2009).
5. Daemen, J. et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease. Circulation 118, 1146-1154 (2008).
6. national Heart, Lung, and Blood institute. Clinical alert: bypass over angioplasty for patients with diabetes. US National Library of Medicine [online], http://www.nlm.nih.gov/databases/ alerts/bypass-diabetes.html (1995).
7. Patel, M. R. et al. ACCF/sCAi/sTs/AATs/AHA/ AsnC 2009 appropriateness criteria for coronary revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, society for Cardiovascular Angiography and interventions, society of Thoracic surgeons, American Association for Thoracic surgery, American Heart Association, and the American society of nuclear Cardiology endorsed by the American society of echocardiography, the Heart Failure society of America, and the society of Cardiovascular Computed Tomography. J. Am. Coll. Cardiol. 53, 530-553 (2009).
8. nordman, A. J., Bucher, H., Hengstler, P., Harr, T. & Young, J. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction. Cochrane Database of Systematic Reviews, issue 2. Art. no.:CD005313. doi:10.1002/14651858.CD005313 (2005).
9. Dauerman, H. L. Percutaneous coronary intervention, diabetes mellitus, and death. J. Am. Coll. Cardiol. 55, 1076-1079 (2010).
10. BARi 2D study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N. Engl. J. Med. 360, 2503-2515 (2009).